Answers are grounded in this paper and cite their sources.
Phase II trial shows preserved gonadal function and fertility in Hodgkin lymphoma patients after Nivolumab-AVD treatment, indicating a positive outcome.
In 82 patients with classic Hodgkin lymphoma, stable gonadal hormone levels were observed up to 24 months after nivolumab and AVD (N-AVD) first-line treatment in the NIVAHL trial. These findings suggest preserved gonadal function and fertility following 4×N-AVD. NCT03004833
No takes yet. Share an insight, caveat, or question.
Robertz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: